Elevated expression of toll-like receptor 4 is associated with NADPH oxidase-induced oxidative stress in B cells of children with autism
•B cells of children with autism spectrum disorder (ASD) had increased TLR4/NF-kB expression.•B cells of children with ASD had increased expression of NADPH oxidase.•B cells of children with ASD had deficiency of enzymatic antioxidants.•NF-kB inhibition reduced LPS-induced NOX2 upregulation in ASD B...
Saved in:
Published in | International immunopharmacology Vol. 84; p. 106555 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Netherlands
Elsevier B.V
01.07.2020
Elsevier BV |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | •B cells of children with autism spectrum disorder (ASD) had increased TLR4/NF-kB expression.•B cells of children with ASD had increased expression of NADPH oxidase.•B cells of children with ASD had deficiency of enzymatic antioxidants.•NF-kB inhibition reduced LPS-induced NOX2 upregulation in ASD B cells.
Autism spectrum disorder (ASD) is a childhood disorder with neurodevelopmental dysfunction which manifests as impairment in social behavior and communication skills. B cells play an important role in immune dysfunction where toll-like receptor 4 (TLR4) may contribute through oxidative inflammatory process. TLR4 related signaling and oxidative stress have been reported in the periphery of ASD subjects, however it has not been evaluated in peripheral B cells of ASD subjects and compared with typically developing control (TDC) children. This study evaluated TLR4 expression and related signaling [Bruton’s tyrosine kinase (BTK), spleen tyrosine kinase (SYK), NF-kB, NADPH oxidase (NOX2), nitrotyrosine, superoxide dismutase (SOD)] in ASD and TDC subjects. Current investigation in B cells shows that ASD subjects have increased TLR4 expression and oxidative stress as exhibited by upregulated NOX2 and nitrotyrosine expression as compared to TDC subjects. B cell relevant pathways, BTK/SYK/NF-kB were also upregulated in B cells of ASD group. Treatment with TLR4 agonist, LPS led to upregulation of NOX2 and nitrotyrosine in B cells of ASD whereas it had no significant effect on TDC subjects. Treatment with NF-kB inhibitor caused inhibition of LPS-induced upregulation of NOX2 and nitrotyrosine in B cells of ASD. Therefore, current investigation proposes the notion that TLR4 expression is elevated in B cells which is associated with increased NF-kB signaling and oxidant stress in ASD subjects. In short, peripheral B cells could contribute to systemic oxidative inflammation and contribute to the immune dysfunction in ASD. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ISSN: | 1567-5769 1878-1705 1878-1705 |
DOI: | 10.1016/j.intimp.2020.106555 |